What You Need To Know About The Google IPO

Stocks are
lower Monday as investors worry about the Q2 earnings outlook.
 
This is a busy week for earnings. ExxonMobil
(
XOM |
Quote |
Chart |
News |
PowerRating)
is scheduled to
report on Thursday; Chevron Texaco
(
CVX |
Quote |
Chart |
News |
PowerRating)
reports on Tuesday. Mylan
Labs

(
MYL |
Quote |
Chart |
News |
PowerRating)
will acquire King Pharmaceuticals in a stock swap worth about
$4 billion.

Google said its IPO
would offer 24.6 million shares priced between $108 and $135/share, making the
deal worth as much as $3.3 billion, with a market cap of 36.25 billion. The
company plans to list on the Nasdaq with the symbol “GOOG.”  The company
will be coming in at 60 times earnings; Yahoo, by contrast, is trading at 110
times earnings.The company will sell 14.1 million shares with insiders selling
another 10.5 million shares. After the offering, co-founders Sergey Brin and
Larry Page will retain about 16% each of Google voting power. Q2 profits for the
search engine company rose 24% for last quarter. The road show begins tonight
in New York.

After the close today, look for
earnings from Centex
(
CTX |
Quote |
Chart |
News |
PowerRating)
(1.29 estimate) and American Express
(
AXP |
Quote |
Chart |
News |
PowerRating)
(estimate 0.67).

Dow -21.90 9940.24
S&P 500 -5.11 1081.09
Nasdaq -15.19 1833.90

Strong today are: Utilities

(
UTY.X |
Quote |
Chart |
News |
PowerRating)
+0.41%, Telecom
(
XTC.X |
Quote |
Chart |
News |
PowerRating)
+0.20%.

Weak today are: Biotech
(
BTK.X |
Quote |
Chart |
News |
PowerRating)
-2.68%. Amex Gold Bugs
(
HUI.X |
Quote |
Chart |
News |
PowerRating)
-2.27%,
Semis

(
SOX.X |
Quote |
Chart |
News |
PowerRating)
-1.75%.

The dollar
is -0.26 at 89.00

Gold is -2.20 at 389.70

Crude Oil is -0.23 at
41.48

Volume is 766 million on
the NYSE, and 957 million on the Nasdaq.

Market breadth is negative

NYSE Issues
Advancing 988 Up Vol 178
Declining 2157 Down Vol 535
Ratio 2.18 3.00
Nasdaq
Advancing 885 Up Vol 236
Declining 2068 Down Vol 668
Ratio 2.33 2.83

Stocks in the news:

Tyson Foods
(
TSN |
Quote |
Chart |
News |
PowerRating)
said its
quarterly earnings doubled from a year ago but the full year forecast
disappointed the Street. TSN is trading at 19.05, down 0.90.

Even after a large charge related to its
Taxus stent, the net at Boston Scientific
(
BSX |
Quote |
Chart |
News |
PowerRating)
nearly tripled. BSX
is trading at 35.62, up 2.03.

Merck
(
MRK |
Quote |
Chart |
News |
PowerRating)
and Schering
Plough

(
SGP |
Quote |
Chart |
News |
PowerRating)
won FDA approval to sell a 2:1 cholesterol pill, Vytorin,
which was found to be as effective as Pfizer’s
(
PFE |
Quote |
Chart |
News |
PowerRating)
Lipitor. PFE is
trading at 31.48, down 0.82.

Brice Wightman

bricew@tradingmarkets.com